Corteva, Inc. (CTVA): Results of Operations and Financial Condition
Corteva, Inc. (CTVA) filed an SEC Form 8-K — Results of Operations and Financial Condition. 1 News Release Corteva Delivers Strong 1H 2026, Raises FY 2026 Outlook, On-Track for October 1 Separation • Seed 1H results reflect continued value capture on latest in-demand germplasm and trait technologies, including licensing growth • Crop Protection 1H demand for new product
How this was made
The 30-second read
Why it matters
Traders can update models using the reported income statement, cash flow, and segment sales. The excerpt highlights a large operating cash outflow over six months and notable restructuring and separation costs, which may affect quality-of-earnings assessments.
Market read
This is a primary financial disclosure that can move expectations for ag input demand and cash conversion, but the excerpt lacks explicit forward guidance.
What to watch
Operating cash flow for continuing operations is negative ($-3,345M for six months), and deferred revenue swings sharply, which may matter more than net income for traders.
Q2 2026 net sales were $6,379 million and net income attributable to Corteva was $1,161 million, versus $6,456 million and $1,314 million in the prior-year quarter.
Seed sales were essentially unchanged and Seed Operating EBITDA increased, but consolidated net sales, Crop Protection sales, GAAP income, and GAAP diluted EPS were below the prior-year quarter. First-half operating cash flow was negative and included $1,140 million of pension and OPEB contributions.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| Net salesGAAP | $6,379 million | – | $ (77) (1) % |
| Cost of goods soldGAAP | $2,718 million | – | – |
| Research and development expenseGAAP | $388 million | – | – |
| Selling, general and administrative expensesGAAP | $1,164 million | – | – |
| Amortization of intangiblesGAAP | $194 million | – | – |
| Restructuring and asset related charges - netGAAP | $49 million | – | – |
| Separation costsGAAP | $79 million | – | – |
| Other income (expense) - netGAAP | $(115) million | – | – |
| Interest expenseGAAP | $47 million | – | – |
| Income (loss) from continuing operations before income taxesGAAP | $1,625 million | – | – |
| Provision for (benefit from) income taxes on continuing operationsGAAP | $408 million | – | – |
| Income (loss) from continuing operations after income taxesGAAP | $1,217 million | – | – |
| Income (loss) from discontinued operations after income taxesGAAP | $(52) million | – | – |
| Net income (loss)GAAP | $1,165 million | – | – |
| Net income (loss) attributable to CortevaGAAP | $1,161 million | – | – |
| Diluted earnings (loss) per share of common stockGAAP | $1.73 | – | – |
| Diluted earnings (loss) per share of common stock from continuing operationsGAAP | $1.81 | – | – |
| Basic earnings (loss) per share of common stockGAAP | $1.73 | – | – |
| Organic Salesnon-GAAP | $6,322 million | – | $ (134) (2) % |
| Operating EBITDAnon-GAAP | $2,261 million | – | – |
| Seed Operating EBITDAnon-GAAP | $1,966 million | – | – |
| Crop Protection Operating EBITDAnon-GAAP | $342 million | – | – |
| Corporate Expensesnon-GAAP | $(47) million | – | – |
| Six Months Ended June 30 Net salesGAAP | $11,284 million | – | – |
| Six Months Ended June 30 Net income attributable to CortevaGAAP | $1,881 million | – | – |
| Six Months Ended June 30 diluted earnings (loss) per share of common stockGAAP | $2.80 | – | – |
| Six Months Ended June 30 Operating EBITDAnon-GAAP | $3,699 million | – | – |
| Six Months Ended June 30 cash provided by (used for) operating activitiesGAAP | $(3,357) million | – | – |
| Six Months Ended June 30 capital expendituresGAAP | $(203) million | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| SeedOrganic sales change was $ (13) — %; price & portfolio / product mix was 3 % and volume was (3) %. | $4,532 million | – | $ (5) — % |
| Crop ProtectionOrganic sales change was $ (121) (6) %; price & portfolio / product mix was (4) %, volume was (2) %, and currency was 2 %. | $1,847 million | – | $ (72) (4) % |
| CornOrganic sales change was $ (103) (3) %; price & portfolio / product mix was 4 % and volume was (7) %. | $2,868 million | – | $ (93) (3) % |
| SoybeanOrganic sales change was $ 59 5 %; price & portfolio / product mix was (1) % and volume was 6 %. | $1,318 million | – | $ 61 5 % |
| Other oilseedsOrganic sales change was $ 40 22 %; price & portfolio / product mix was 11 %, volume was 11 %, and currency was 1 %. | $228 million | – | $ 42 23 % |
| HerbicidesNo product-line price-volume-currency analysis was included in the provided filing text. | $932 million | – | – |
| InsecticidesNo product-line price-volume-currency analysis was included in the provided filing text. | $399 million | – | – |
| FungicidesNo product-line price-volume-currency analysis was included in the provided filing text. | $263 million | – | – |
| BiologicalsNo product-line price-volume-currency analysis was included in the provided filing text. | $86 million | – | – |
Capital returns
- Six Months Ended June 30, 2026 repurchase of common stock: $(500) million.
- Six Months Ended June 30, 2026 dividends paid to stockholders: $(241) million.
What drove it
- Total Q2 GAAP net sales change was $ (77) (1) %, while organic change was $ (134) (2) %.
- Seed Q2 GAAP net sales change was $ (5) — %, with 3 % price & portfolio / product mix offset by (3) % volume.
- Crop Protection Q2 GAAP net sales change was $ (72) (4) %, with (4) % price & portfolio / product mix and (2) % volume, partly offset by 2 % currency.
- Seed Operating EBITDA was $1,966 million, compared with $1,863 million.
- Crop Protection Operating EBITDA was $342 million, compared with $334 million.
Concerns
- Q2 net sales were $6,379 million, compared with $6,456 million in the prior-year quarter.
- Q2 income from continuing operations after income taxes was $1,217 million, compared with $1,382 million.
- Q2 net income attributable to Corteva was $1,161 million, compared with $1,314 million.
- Q2 diluted earnings per share was $1.73, compared with $1.92.
- Other income (expense) - net was $(115) million, compared with $103 million.
- Separation costs were $79 million; the prior-year-quarter amount was reported as —.
- Six Months Ended June 30 cash provided by (used for) operating activities was $(3,357) million, compared with $(1,162) million.
What to watch
- Seed volume, which was (3) % in the Q2 Seed price-volume-currency analysis.
- Crop Protection price & portfolio / product mix, which was (4) % in the Q2 Crop Protection price-volume-currency analysis.
- Corn sales, which were $2,868 million compared with $2,961 million.
- The cash balance of $2,365 million and short-term borrowings of $3,193 million at June 30, 2026.
- Pension and OPEB contributions, which were $(1,140) million for the Six Months Ended June 30, 2026.
Balance sheet and cash flow
- Cash and cash equivalents at June 30, 2026: $2,365 million.
- Short-term borrowings at June 30, 2026: $3,193 million.
- Long-term debt at June 30, 2026: $1,682 million.
- Six Months Ended June 30, 2026 cash provided by (used for) operating activities - continuing operations: $(3,345) million.
- Six Months Ended June 30, 2026 cash provided by (used for) operating activities: $(3,357) million.
- Six Months Ended June 30, 2026 cash provided by (used for) investing activities: $(247) million.
- Six Months Ended June 30, 2026 cash provided by (used for) financing activities: $1,530 million.
- Cash, cash equivalents and restricted cash equivalents at end of period: $2,619 million.
- Six Months Ended June 30, 2026 pension and OPEB contributions: $(1,140) million.
Analysis
Corteva reported Q2 2026 GAAP net sales of $6,379 million, compared with $6,456 million in the prior-year quarter. The filing's price-volume-currency analysis showed a $ (77) (1) % GAAP sales change and a $ (134) (2) % organic sales change. Seed sales were $4,532 million, compared with $4,537 million, while Crop Protection sales were $1,847 million, compared with $1,919 million.
Seed was broadly stable at the sales level, but its mix shifted materially by product. Corn sales were $2,868 million versus $2,961 million, while soybean sales were $1,318 million versus $1,257 million and other oilseeds sales were $228 million versus $186 million. The Seed analysis showed 3 % price & portfolio / product mix and (3) % volume. Seed Operating EBITDA rose to $1,966 million from $1,863 million.
Crop Protection was the principal reported sales drag. Its Q2 analysis identified (4) % price & portfolio / product mix and (2) % volume, partly offset by 2 % currency. Nonetheless, Crop Protection Operating EBITDA was $342 million, compared with $334 million. At the consolidated level, Operating EBITDA was $2,261 million versus $2,164 million, while GAAP income from continuing operations after income taxes was $1,217 million versus $1,382 million. The GAAP comparison includes other income (expense) - net of $(115) million versus $103 million and separation costs of $79 million.
Capital allocation included $(500) million of common-stock repurchases and $(241) million of dividends paid during the Six Months Ended June 30, 2026. Operating cash flow for that six-month period was $(3,357) million, compared with $(1,162) million, and pension and OPEB contributions were $(1,140) million. Cash and cash equivalents were $2,365 million at June 30, 2026, while short-term borrowings were $3,193 million and long-term debt was $1,682 million.
No forward outlook or management commentary was included in the provided filing text. The reported period therefore leaves attention on whether Seed price and product mix can continue to offset volume pressure, whether Crop Protection can improve its reported price and volume trends, and the progression of seasonal cash flow after the first-half cash use.
Not in the filing
stated, not guessed- Forward guidance, including revenue, gross margin, operating expenses, tax rate, and other guided metrics, was not included in the provided filing text.
- Previous-period outlook was not provided.
- Gross profit and gross margin were not reported.
- Free cash flow was not reported.
- A Q2-only operating cash flow figure was not reported.
- A Q2-only capital expenditures figure was not reported.
- A dividend per share was not reported.
- Non-GAAP EPS was not reported.
- Prior-quarter figures and quarter-over-quarter changes were not reported.
- An effective tax rate was not reported.
- Named executive quotes were not included in the provided filing text.
- The provided filing text ends during the Crop Protection product-line price-volume-currency analysis; product-line sales-change drivers for Crop Protection were not available.
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
The SEC 8-K (Item 2.02) reports Corteva’s results of operations and financial condition, including consolidated statements of operations, balance sheet, cash flows, and segment/geographic net sales.
Ticker impact
Corteva filed an 8-K with Q2 and six-month results, including net sales of $6,379M (Q2) and net income of $1,165M.
Likely modest, unless investors focus on specific line items like operating cash flow decline and restructuring/separation charges.
This is a primary SEC filing with concrete numbers (income statement, balance sheet, cash flow, segment sales), but the excerpt does not include guidance or management commentary that would typically create a larger repricing catalyst.
Market effects
Results and segment sales (Seed and Crop Protection) can inform read-across for ag input demand and pricing trends.
Geographic seed and crop protection sales breakdown may affect regional ag-cycle expectations.
As a large global agriculture inputs company, the print can influence broader sentiment around commodity-linked input demand.
Counterpoint
Earnings can look solid while operating cash flow deteriorates, so equity reaction may be muted or negative if cash conversion is the key focus.
Key entities
- companyCorteva, Inc.
Agriculture inputs company filing an 8-K with Q2 and six-month financial results and segment sales.
